Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...
Hosted on MSN14h
2 Beaten-Down Dividend Stocks to Buy and Hold
Here are two brilliant options along those lines: CVS Health (NYSE: CVS) and Bristol Myers Squibb (NYSE: BMY). Find out why, ...
WJW-TV Cleveland on MSN4h
Docuseries spotlights wrestling rivalry between local high schools
A high school wrestling rivalry for the ages is being revisited through a four-part docuseries called "Clash of Dynasties" – highlighting the battles between St. Edward and Walsh Jesuit in the 1980s ...
FierceBiotech13h
BMS' CAR-T cracks down on lupus, achieving sustained responses in phase 1
Bristol Myers Squibb has linked its CD19-directed CAR-T cell therapy to sustained clinical responses in people with systemic ...
Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug
Bristol Myers Squibb was hit on Thursday with a $6.7 billion lawsuit claiming it cheated former Celgene shareholders by ...
‘All vacant govt. quota seats in private engineering colleges should be allotted through KEA only’
KEA requests State government to prevent engineering seat blocking racket by ensuring all vacant seats are allotted through ...